Showing 20 of 66 recruiting trials for “Cardiogenic shock”
Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI
👨⚕️ Dmitry Pevzner, MD, National Medical Research Center for Cardiology, Ministry of Health of Russian Federation📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT05752383 ↗
The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care
Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial
👨⚕️ François CREMIEUX, Assistance Publique Hopitaux De Marseille📍 1 site📅 Started Dec 2022View details ↗
RecruitingNCT06827314 ↗
Pharmacological and Mechanical Support Approaches in the Management of Acute Heart Failure in the Regional Network Model for the Management of Cardiogenic Shock
👨⚕️ Luciano G Potena, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Dec 2022View details ↗
Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
🏥 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)📍 1 site📅 Started Oct 2022View details ↗
Pulmonary Artery Catheter in Cardiogenic Shock Trial
RecruitingNCT05728359 ↗
Genomic Determinants of Outcome in Cardiogenic Shock
RecruitingNCT05426083 ↗
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
Enrolling by InvitationNCT05800951 ↗
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
RecruitingNCT05185492 ↗
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
👨⚕️ Rebecca Mathew, MD, Ottawa Heart Institute Research Corporation📍 3 sites📅 Started Mar 2022View details ↗
RecruitingNCT05465200 ↗
Lower Silesia Cardiogenic Shock Initiative
Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock
👨⚕️ Alain COMBES, MD, PhD, Centre Hospitalier Universitaire Pitié-Salpêtrière Paris📍 1 site📅 Started Oct 2021View details ↗
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RecruitingNCT04295252 ↗
Altshock-2 REGISTRY
RecruitingNCT05415332 ↗
The Current Status and Clinical OUTcomes of Cardiogenic Shock Patients And the Role of Specialist in Cardiovascular Critical Care Unit
👨⚕️ Chul-Min Ahn, Yonsei University Health system Severance Hospital📍 1 site📅 Started Jun 2020View details ↗
RecruitingNCT04117230 ↗
CARDSUP - SWISS Circulatory Support Registry
RecruitingNCT03378739 ↗
Inova Cardiogenic Shock Registry (INOVA SHOCK)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →